Back to search

United Kingdom· GB-APID-45404211000001107

Atenza XL 18mg tablets

A methylphenidate product containing methylphenidate, registered in United Kingdom by Exeltis UK Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC N06BA04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedAtenza XL 18mg tabletsATCN06BA04REGISTER NO.GB-APID-4540421100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Methylphenidate is registered in 18 of 19 countries.

Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Methylphenidate · ATC N06BA04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylphenidate costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Methylphenidate · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.87
  • IT Italy$0.68
  • US United States$0.56 (acquisition cost)
  • FR France$0.56
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Methylphenidate
Manufacturer
Exeltis UK Ltd
Country
United Kingdom (GB)
ATC code
N06BA04
ATC class
Methylphenidate
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    08437024360568

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

196 interactions on record for methylphenidate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methylphenidate · interactions on record

196 records

  • 12 severe
  • 45 moderate
  • 3 minor
  • 128 info

Most severe, free to view

  • ProcarbazineL01XB01severe
  • OzanimodL04AA38severe
  • OzanimodL04AE02severe
  • CocaineN01BC01severe

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylphenidate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylphenidate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Concerta, Conmethyl
  • Belgium · Atexam 18 Mg, Atexam 27 Mg
  • Bulgaria · Концерта
  • Cyprus · Concerta
  • Czechia · Balipre, Concerta
  • Germany · 5 Mg, Medikinet, 50 Mg, Medikinet Adult
  • Denmark · Concerta, Equasym Depot
  • Estonia · Affenid, Concerta
  • Spain · Atenza, Concerta
  • Finland · Atexam, Concerta
  • France · Concerta Lp, Lp
  • Greece · Concerta
  • Croatia · Concerta, Mefeda
  • Hungary · Ritalin, Ritalin La
  • Ireland · Concerta Xl, Equasym Xl
  • Iceland · Concerta, Equasym Depot
  • Italy · Equasym, Medikinet
  • Liechtenstein · Concerta, Tuzulby
  • Lithuania · Concerta, Medikinet
  • Luxembourg · Concerta, Equasym Xr
  • Latvia · Medikinet, Medikinet Xl
  • Malta · Concerta, Concerta Xl
  • Netherlands · Concerta, Equasym Xl
  • Norway · Concerta, Delmosart
  • Poland · Adehader, Atenza
  • Portugal · Atexam, Concerta
  • Romania · Clorhidrat De Metilfenidat G.L. Pharma, Concerta
  • Sweden · Affenid, Concerta
  • Slovenia · Concerta
  • Slovakia · Balipre, Concerta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5f3b7969-5fb0-4b79-915c-41693b9dc05e
GET /v1/drugs/5f3b7969-5fb0-4b79-915c-41693b9dc05e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45404211000001107",
  "desc": "Atenza XL 18mg tablets (Exeltis UK Ltd)",
  "form": "Modified-release tablet",
  "vpid": "36123511000001103",
  "source": "dmd",
  "vtm_id": "776752004",
  "strength": "18 mg",
  "substance": "Methylphenidate",
  "ingredient": "Methylphenidate hydrochloride",
  "supplier_code": "40599211000001108"
}

See everything about methylphenidate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.